Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
12/2001
12/06/2001WO2001092228A2 Process for the synthesis of amine ethers from secondary amino oxides
12/06/2001WO2001092225A1 Method for producing indols
12/06/2001WO2001092224A1 Indole derivatives with vascular damaging activity
12/06/2001WO2001092223A1 Process for the preparation of indole derivatives and intermediates of the process
12/06/2001WO2001092218A2 Polyamine analogues as therapeutic and diagnostic agents
12/06/2001WO2001092217A2 Process for the preparation of amidostyrylstilbene-disulphonic acid compounds and novel amidostyrylstilbene-disulphonic acid compounds and their use as fluorescent whitening agents
12/06/2001WO2001092211A1 Compounds exhibiting thrombopoietin-like activities
12/06/2001WO2001092187A1 Method for formulating organic compounds
12/06/2001WO2001091756A2 S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders
12/06/2001WO2001044167A8 Quaternary ammonium compounds and their use as anti-tussive agents
12/06/2001US20010049448 Method for producing aminocarbazoles
12/06/2001US20010049371 Reducing levels of tumor necrosis factor alpha; inhibition of undesireable levels of matrix metalloproteinases
12/06/2001DE10026646A1 Verfahren zur Herstellung von Indolen Process for the preparation of indoles
12/06/2001DE10026645A1 Verfahren zur Formylierung organischer Verbindungen Procedures for the formylation of organic compounds
12/06/2001DE10025329A1 New 6-hydroxy-2,3-dihydro-1H-indole derivatives and analogs, useful in cancer therapy, especially used in low toxicity glycoside or acetal prodrug form for antibody directed enzyme prodrug therapy
12/06/2001CA2410935A1 Novel polyamine analogues as therapeutic and diagnostic agents
12/06/2001CA2410618A1 S-methyl-dihydro-ziprasidone for treatment of psychiatric disorders
12/06/2001CA2407862A1 Process for the preparation of indole derivatives and intermediates of the process
12/06/2001CA2406979A1 Indole derivatives with vascular damaging activity
12/05/2001EP1159291A1 C-terminal modified (n-substituted)-2-indolylcarbonyldipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
12/05/2001EP1159269A1 Anti-imflammatory indole derivatives
12/05/2001EP1159268A1 N-SUBSTITUTED BENzOYL INDOLES AS ESTROGENIC AGENTS
12/05/2001EP1159267A1 N-substituted indolines as estrogenic agents
12/05/2001EP1158985A1 OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
12/05/2001EP0937036B1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors
12/05/2001EP0866059B1 Novel heterocyclic derivatives and medicinal use thereof
12/05/2001EP0851856B1 Indole derivatives as melatoninergic analogues
12/05/2001EP0636026B1 Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor
12/05/2001CN1325399A Pyrroloindoles, pyridoindoles and azepinoindoles as 5-HT2c agonists
12/05/2001CN1325397A 2-piperazino alkylatnino benzoazole derivatives: dopamine receptor subtype sepcific ligands
12/05/2001CN1325384A Anthranilic acid amides and the use thereof as medicaments
12/05/2001CN1325380A Benzene derivatives and medical use thereof
12/05/2001CN1325376A Novel compounds and medicinal use thereof
12/05/2001CN1325304A 5HT1 receptor agonists and metoclopramide for treatment of migraine
12/05/2001CN1075808C Aniline derivatives having nitrogen monoxide synthase inhibitory activity
12/04/2001USH2007 Insecticidal N-heterocyclylalkyl-or N-[(polycyclyl)alkyl]-N′substituted piperazines
12/04/2001US6326501 Using basic catalysts; enzyme inhibitors
12/04/2001US6326399 O-benzyloxime ethers and crop protection agents containing these compounds
12/04/2001US6326398 Oxamic acids and derivatives as thyroid receptor ligands
12/04/2001US6326391 Inhibitors of multidrug transporters
12/04/2001US6326369 Bicyclic quinone compounds, their production and use
12/04/2001US6326367 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
12/04/2001US6326153 Polynucleotide sequencing
12/04/2001US6326133 Cyanine dyes
12/04/2001CA2042327C Pyrrolo¬2,3-b|indole-ketones and analogs, a process for their preparation and their use as medicaments
12/04/2001CA2000553C Process for the preparation of 7-substituted-hept-6-enoic and -heptanoic acids and derivatives and intermediates thereof
12/04/2001CA1341324C Esterase enzymes used in the process for the preparation of 2-arylpropionic acids
11/2001
11/29/2001WO2001090717A2 Linker arms for nanocrystals and compounds thereof
11/29/2001WO2001090716A2 Linker arms for nanocrystals and compounds thereof
11/29/2001WO2001090113A1 Hydroxylamine esters as polymerization initiators
11/29/2001WO2001090074A2 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a)
11/29/2001WO2001090069A1 Novel calcium receptor active molecules and method for preparing same
11/29/2001WO2001090067A1 Tyrosine phosphatase inhibitors
11/29/2001WO2001063345A3 Photochemically controlled photonic crystal diffraction
11/29/2001US20010047031 Heterocyclic compounds useful as NMDA receptor selective subtype blockers
11/29/2001US20010047029 Diindol-3-ylphenylcarbonium and triindol-3-ylcarbonium derivatives (turbomycins); broad spectrum antibiotic and fungicidal activity
11/29/2001US20010047027 2-((1R)-9-p-(chlorobenzyl)-8-((R or S)-methylsulfinyl)-2,3,4,9-tetrahydrocarbazole)-1-acetic acid and salts; alergic rhinitis treatment
11/29/2001US20010046975 Fungicides for the control of take-all disease of plants
11/29/2001US20010046958 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors
11/29/2001US20010046953 Useful in laundry, automatic dishwashing and hard surface cleaning
11/29/2001US20010046612 Hole transporting compounds having good thermal stability for organic electroluminescent device and method for production thereof
11/29/2001CA2410338A1 Tyrosine phosphatase inhibitors
11/29/2001CA2408727A1 Benzophenones as inhibitors of il-1.beta. and tnf-.alpha.
11/28/2001EP1158321A2 Dichroic light polarizers with non-periodic arrangement of different polarizing elements
11/28/2001EP1158320A2 Dichroic light polarizers
11/28/2001EP1157984A2 Trypsin substrate and diagnostic device, and method of using same
11/28/2001EP1157704A1 Remedies or preventives for ischemic reflow failure
11/28/2001EP1157017A1 N-substituted imide derivatives with serotonergic activity
11/28/2001EP1157001A1 Oxamic acids and derivatives as thyroid receptor ligands
11/28/2001CN1324346A Method for producing (+)-exo-6-phenyl-3-azabicyclo-[3.2.O] heptanes
11/28/2001CN1323794A Novel hetero naphthenic benzcyclobutane and heterocyclo acryl benzcyclobutane compound, their prepn. method and pharmaceutical composites
11/28/2001CN1075499C Quninolone-acid naphthyridone carboxylic acid derivatives
11/27/2001US6323235 Benzene-condensed heterocyclic derivatives and their uses
11/27/2001US6323234 Methods to treat gastrointestinal lesions and to reduce drug-induced gastrointestinal or renal toxicity
11/27/2001US6323233 Diindole compounds as antiinflammatory agents
11/27/2001US6323229 Compounds are useful psychotherapeutics and are potent agonists and/or antagonists of the serotonin 1a (5-ht 1a) and/or serotonin 1d (5-ht 1d) for treatment of hypertension, depression, generalized anxiety disorder
11/27/2001US6323228 3-substituted indole angiogenesis inhibitors
11/27/2001US6323227 Prodrugs
11/27/2001US6323223 Ccr-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use and methods for preparing these compounds.
11/27/2001US6323194 Muscarinic agonists and antagonists
11/27/2001US6322909 2,4-bis(2-benzoindolinylidene)-methyl)-squarylium compounds
11/22/2001WO2001087887A2 Neuroprotective and anti-proliferative compounds
11/22/2001WO2001087837A1 Process and intermediates for the preparation of 1-(9h-carbazol-4-yloxy)-3-[2-(2-methoxy-phenoxy)-ethylamino]-propan-2-ol, carvedilol or acid addition salts thereof
11/22/2001WO2001087836A1 Novel $g(b crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same
11/22/2001WO2001087835A1 Α crystalline form of perindopril tert-butylamine salt
11/22/2001WO2001087834A1 Melanin-concentrating hormone antagonist
11/22/2001WO2001087828A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
11/22/2001WO2001087308A1 Treatment of fibromyalgia and chronic fatigue syndrome
11/22/2001WO2001087299A1 Aralkyl ester soft drugs
11/22/2001WO2001027080A3 5-substituted indolinones and use thereof as kinase and cyclin/cdk complex inhibitors
11/22/2001US20010044544 Useful as high energy oxidizing agents in explosive and propellant formulations, and drugs for vasodilation
11/22/2001US20010044460 Ophthalmic compositions for treating ocular hypertension
11/22/2001US20010044455 Method of treatment for decreasing mortality resulting from congestive heat failure
11/22/2001US20010044443 Fungicidal active compound combinations
11/22/2001US20010044439 Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as H3 antagonists
11/22/2001US20010044434 Treating timidity and enhancing libido in postmenopausal women, or treating male sexual dysfunction by administering to a patient in need thereof an effective amount of an estrogen agonist/antagonist
11/22/2001CA2408913A1 Melanin-concentrating hormone antagonist
11/22/2001CA2407103A1 Process and intermediates for the preparation of 1-(9h-carbazol-4-yloxy)-3-[2-(2-methoxy-phenoxy)-ethylamino]-propan-2-ol, carvedilol or acid addition salts thereof
11/22/2001CA2407099A1 Aralkyl ester soft drugs
11/22/2001CA2404704A1 Treatment of fibromyalgia and chronic fatigue syndrome